Today, Senator Rick Scott joined Senator Gary Peters and several of their colleagues in the introduction of the bipartisan Mapping America’s Pharmaceutical Supply (MAPS) Act, to codify a recent Trump administration Executive Order to secure essential medicine supply chains. The MAPS Act will direct the Department of Health and Human Services (HHS) to maintain and publish a list of essential medicines and conduct risk assessments to identify vulnerabilities such as overreliance on foreign sources and cybersecurity threats.
“I’m proud to support the bipartisan MAPS Act to strengthen our essential medicine supply chains and reduce America’s dangerous overreliance on Communist China for critical drug ingredients,” Sen. Scott said. “This legislation will enhance federal coordination and supply chain visibility so we can better protect patients, prevent drug shortages, and ensure our national security isn’t compromised by foreign adversaries.”
This bill also requires mapping of the entire pharmaceutical supply chains—from key ingredients to distribution—to improve transparency and preparedness, and mandate the Department of Defense (DOD) to report on U.S. reliance on Communist China for critical drug components. This builds on Senator Scott’s provision included in the Fiscal Year 2025 National Defense Authorization Act which requires the DOD to develop a plan to secure their pharmaceutical supply chain by promoting domestically sourced drugs and not use Chinese ingredients or key starting materials.
